The surge in genomics and proteomics research for disease diagnosis, drug discovery, and personalized medicine is a primary driver of the DNA microarray market. Applications in Disease Diagnostics: ...
In 2005, two landmark papers describing novel cycle-array sequencing methods ushered in a new era in genetics. Known at the time as next-generation sequencing (NGS), these methods are now more ...
Comparative genomic hybridization (CGH) was developed to identify pathogenic DNA copy-number changes (e.g., duplications, deletions) on a genome-wide scale, and to map these changes to genomic ...
According to a recent report by Market.us, the Global DNA Microarray Market size is expected to be worth around USD 4,593.7 Million by 2033 from USD 1,994.6 Million in 2023, growing at a CAGR of 8.7% ...
The research community's rapid acceptance of microarrays notwithstanding, technical challenges remain. Biochip developers continue to grapple with these issues while upgrading their offerings and ...
Thermo Fisher Scientific, announced the launch of a new chromosomal microarray designed to improve cytogenetic research lab productivity, efficiency and profitability with an industry-leading two-day ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback